The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes

scientific article

The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2125.1994.TB04316.X
P932PMC publication ID1364832
P698PubMed publication ID7946932
P5875ResearchGate publication ID15252171

P2093author name stringB K Park
S Madden
T F Woolf
V Spaldin
W F Pool
P2860cites workProtein measurement with the Folin phenol reagentQ20900776
Enoxacin raises plasma theophylline concentrationsQ28261528
Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1Q28319041
THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATUREQ29547810
Tolbutamide 4-hydroxylase activity of human liver microsomes: effect of inhibitorsQ34420999
Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studiesQ34447046
Inhibitory effects of neuroleptics on debrisoquine oxidation in manQ34447792
The influence of quinolone derivatives on theophylline clearanceQ34448229
The effects of cimetidine on the oxidative metabolism of estradiolQ34535925
Danger of interaction between ciprofloxacin and theophyllineQ36895731
Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot studyQ38719669
Pharmacokinetic interactions of cimetidine 1987.Q39662361
In vitro approaches can predict human drug metabolismQ40784165
In vitro methods for assessing human hepatic drug metabolism: their use in drug developmentQ40817420
Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbarylQ41111368
In vitro effects of quinoline derivatives on cytochrome P-450 and aminopyrine N-demethylase activity in rat hepatic microsomesQ41918372
Inhibition of drug metabolism by the antimalarial drugs chloroquine and primaquine in the rat.Q41921824
Inhibition of metoprolol metabolism by chloroquine and other antimalarial drugsQ41944104
The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.Q42284991
The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomesQ43205011
Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolitesQ43222882
Cimetidine interaction with liver microsomes in vitro and in vivo. Involvement of an activated complex with cytochrome P-450.Q43411735
A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study GroupQ44110810
Effects of tetrahydroaminoacridine on liver function in patients with Alzheimer's diseaseQ44223667
Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1.Q51671371
Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.Q52259713
Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.Q52401805
Tacrine in Alzheimer's diseaseQ56763713
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's diseaseQ67516972
Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomesQ68168251
Metabolism of the contraceptive steroid desogestrel by human liver in vitroQ68411414
Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamideQ68411894
Decrease of caffeine elimination in man during co-administration of 4-quinolonesQ68781944
Concomitant administration of cyclosporin and ketoconazole in renal transplant recipientsQ69375733
Evidence for induction of hepatic microsomal cytochrome P-450 by cimetidine: binding and kinetic studiesQ70291786
Cimetidine potentiates the anticoagulant effect of warfarin by inhibition of drug metabolismQ71259532
Interaction of cimetidine with cytochrome P450 and effect on mixed-function oxidase activities of liver microsomesQ72215172
Quinolones and raised plasma concentrations of theophyllineQ72586826
Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species differenceQ72658526
An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomesQ72870562
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)15-22
P577publication date1994-07-01
P1433published inBritish Journal of Clinical PharmacologyQ176044
P1476titleThe effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes
P478volume38

Reverse relations

cites work (P2860)
Q35802571Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease
Q73647451Characterization of the induction of rat microsomal cytochrome P450 by tacrine
Q40472033Clinical Pharmacokinetics of Tacrine
Q46675103Consumption of charcoal-broiled meat as an experimental tool for discerning CYP1A2-mediated drug metabolism in vivo
Q47651680Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy.
Q36061821Drug bioactivation, covalent binding to target proteins and toxicity relevance
Q78019948Effect of tacrine hydrochloride on hepatic drug metabolism
Q41334623Human P450 metabolism of warfarin
Q41172369Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism
Q46986336In-vitro stability and metabolism of a tacrine-silibinin codrug
Q34741428Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans*
Q34732916Inhibition of tacrine oral clearance by cimetidine
Q89603158Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Q24791908NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant
Q34994964New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme
Q41128196Noninterference of cytochrome P4501A2 in the cytotoxicity of tacrine using genetically engineered V79 Chinese hamster cells for stable expression of the human or rat isoform and two human hepatocyte cell lines
Q37611786Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.
Q43244977Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
Q36179528Role of metabolism in drug-induced idiosyncratic hepatotoxicity
Q71856356Species variation in the bioactivation of tacrine by hepatic microsomes
Q35015993Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.
Q32103802Summary of information on human CYP enzymes: human P450 metabolism data
Q48760407Tacrine and its analogues impair mitochondrial function and bioenergetics: a lipidomic analysis in rat brain.
Q73567801The effect of velnacrine on the mixed function oxidase system
Q41401684The metabolism of psychoactive drugs: a review of enzymatic biotransformation and inhibition
Q38561490Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
Q34617272Tribuli fructus constituents protect against tacrine-induced cytotoxicity in HepG2 cells
Q36851934Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions